“Results of Two Sequential Phase II Studies of Interleukin-2 (IL2) in Metastatic Renal Cell Carcinoma and Melanoma: High-Dose Continuous Intravenous IL2 Infusion and Subcutaneous IL2 Administration in Combination With Alpha Interferon”. Revista de Medicina de la Universidad de Navarra 40, no. 3 (April 11, 2017): 6–12. Accessed July 15, 2025. https://revistas.unav.edu/index.php/revista-de-medicina/article/view/8892.